T-Hub inks MoU with Pharmaceutical Major Novartis to Nurture Health Tech Startups3 years ago Saritha Keshamoni
India’s Biggest Technology Incubator, T-Hub signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
Being leaders in healthcare, NovartisHeadquartered in Basel, Switzerland and has significant foot print in Hyderabad, India, will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow. As a part of the initiatives health, research and development experts from Novartis will mentor and guide startups, in compliance with T-Hub’s mentorship framework and evaluation process, in their respective ventures.
Speaking about Partnership Jay Krishnan, CEO, T-Hub said “We are very excited to collaborate with Novartis. It will bring great value to the ecosystem and HealthTech startups will be greatly benefited. With HealthTech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided through various programs of ours, which will help them scale their business faster,”
Subodh Deshmukh, Global Drug Development India Head, Novartis said, “As a global leader in biomedical innovation, we are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space.” PTI GDK ARS JMF
Here is our previous article about Vodafone Business Services and T-Hub join hands to help start-ups scale http://startuphyderabad.com/vodafone-business-services-t-hub-join-hands-help-start-ups-scale/